Skip to content
PubMed This is a summary of 12 peer-reviewed journal articles Updated
Ophthalmology

Can Stargardt Disease Start in Adulthood? What to Know

At a Glance

Yes. Stargardt disease can first cause noticeable vision symptoms in the 20s, 30s, or even after age 45, despite being genetic from birth. Adult-onset cases may progress more slowly and resemble AMD, so genetic testing plus retinal imaging can help confirm the diagnosis.

Receiving a diagnosis of a genetic eye condition as an adult can be confusing, especially if you have read that Stargardt disease is a “juvenile” condition. Yes, Stargardt disease can start in adulthood. While historically known as “juvenile macular degeneration” because symptoms most often appear between ages 8 and 15, doctors now recognize that adult-onset and late-onset Stargardt are well-documented realities [1][2]. For many patients, symptoms do not become noticeable until their 20s, 30s, or even past the age of 45, even though the underlying genetic cause has been present since birth [1][3].

Why Do Symptoms Appear Later in Life?

Stargardt disease is most often caused by variants in the ABCA4 gene, which provides instructions for clearing away lipofuscin (a toxic waste byproduct) in the retina [4]. Because it is a recessive genetic condition, you generally inherit two disease-causing variants of the gene (usually one from each parent) to develop the disease [4].

However, not all ABCA4 variants affect the eye in the same way. Genetic research shows that adult-onset cases frequently involve inheriting one “severe” variant alongside one “mild” or hypomorphic variant (a gene variation that still functions, just at a reduced level) [1][5]. A common mild variant associated with late-onset Stargardt is p.Asn1868Ile [1][6].

Because a milder variant allows the ABCA4 protein to retain some of its clearing function, it may take much longer for lipofuscin to build up and cause retinal damage [7][8]. This residual function is one reason why symptoms can be delayed for decades compared to childhood-onset cases, though individual outcomes vary widely based on exact genetics and other factors [7][9].

How Does Adult-Onset Stargardt Differ?

Beyond the age at which symptoms begin, adult-onset Stargardt on average behaves somewhat differently than the classic juvenile form, though no single pattern applies to everyone:

  • Slower Average Progression: Structural changes in the retina—such as atrophy (the loss of retinal tissue)—tend to expand more slowly in adults than in children [1][3]. However, this atrophy can still progress silently even if your day-to-day central vision seems stable.
  • Foveal Sparing: Late-onset Stargardt often spares the fovea (the very center of the macula responsible for the sharpest, most detailed vision) early in the disease [1][10]. Central reading vision may be preserved longer, but patients can still experience disabling issues with contrast, glare, color vision, and adjusting from light to dark environments.
  • Milder Vision Loss: Severe visual decline is generally less frequent in adult-onset populations compared to early-onset groups, but vision loss still occurs over time and can vary from stable periods to noticeable decline [2].

The AMD Confusion

Because adult-onset Stargardt is less common, and its visual signs—like yellowish deposits in the retina called flecks—can look remarkably similar to the drusen seen in age-related macular degeneration (AMD), misdiagnosis is common [1][10][11]. In one specialty clinic registry, nearly a quarter of late-onset Stargardt cases were initially misdiagnosed as AMD [11].

Accurate diagnosis requires a comprehensive approach. Genetic testing is important, but it is not a magic bullet—results can be inconclusive or identify variants of uncertain significance. A complete evaluation by a retinal dystrophy specialist should integrate your medical history, genetic test results, and specialized imaging like optical coherence tomography (OCT) and fundus autofluorescence (FAF) to confirm the diagnosis and distinguish it from AMD or other macular conditions [11][4][12].

Common questions in this guide

Can Stargardt disease cause its first noticeable symptoms in adulthood?
Yes. Although Stargardt disease often becomes noticeable between ages 8 and 15, some people do not notice symptoms until their 20s, 30s, or even after age 45. The genetic change is present from birth, but retinal damage may take years to become noticeable.
Why might Stargardt disease stay unnoticed until later in life?
Stargardt disease is usually linked to changes in the ABCA4 gene, which helps the retina clear a waste product called lipofuscin. Some people inherit one more severe change and one milder change, leaving partial gene function and slowing the buildup of this waste. The exact course depends on the person's genetic variants and other factors.
Is adult-onset Stargardt disease the same as age-related macular degeneration?
Not necessarily. Both conditions can cause changes that look similar on a retinal exam, so adult-onset Stargardt disease is sometimes mistaken for age-related macular degeneration. A retinal specialist may combine medical history, genetic testing, and specialized scans such as OCT and fundus autofluorescence to distinguish them.
Does late-onset Stargardt disease usually progress more slowly?
On average, areas of retinal tissue loss expand more slowly in adult-onset Stargardt disease than in childhood-onset disease, and the fovea, the center of the macula, may be spared early. However, progression varies widely, and retinal changes can continue even when day-to-day central vision seems stable. Contrast, glare, color vision, and adapting between light and dark may still be affected.
What tests can help confirm Stargardt disease that starts in adulthood?
Diagnosis usually combines an eye examination with genetic testing and retinal imaging, such as optical coherence tomography, also called OCT, and fundus autofluorescence. Genetic testing can be inconclusive or find a variant whose meaning is uncertain, so results should be interpreted with the examination and imaging by a retinal dystrophy specialist. This combined evaluation also helps distinguish Stargardt disease from age-related macular degeneration and other macular conditions.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.Given my age of symptom onset, do my specific genetic variants suggest a milder or slower-progressing form of Stargardt, and has a genetic counselor reviewed my results?
  2. 2.Can you show me on my OCT or autofluorescence imaging if I have 'foveal sparing,' and what that means for my current and future central vision?
  3. 3.What specific imaging tests will you use to track my retinal atrophy, and how frequently should we monitor those changes?
  4. 4.What low-vision rehabilitation resources or practical strategies do you recommend to help with daily tasks like managing glare, reading, or driving safely?

Questions For You

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

References

References (12)
  1. 1

    Study of Late-Onset Stargardt Type 1 Disease: Characteristics, Genetics, and Progression.

    Li CHZ, Pas JAAH, Corradi Z, et al.

    Ophthalmology 2024; (131(1)):87-97 doi:10.1016/j.ophtha.2023.08.011.

    PMID: 37598860
  2. 2

    VISUAL ACUITY IN PATIENTS WITH STARGARDT DISEASE AFTER AGE 40.

    Collison FT, Fishman GA

    Retina (Philadelphia, Pa.) 2018; (38(12)):2387-2394 doi:10.1097/IAE.0000000000001903.

    PMID: 29068916
  3. 3

    Prospective Cohort Study of Childhood-Onset Stargardt Disease: Fundus Autofluorescence Imaging, Progression, Comparison with Adult-Onset Disease, and Disease Symmetry.

    Georgiou M, Kane T, Tanna P, et al.

    American journal of ophthalmology 2020; (211()):159-175 doi:10.1016/j.ajo.2019.11.008.

    PMID: 31812472
  4. 4

    [Clinical and genetic aspects of ABCA4-associated inherited retinal diseases].

    Sheremet NL, Strelnikov VV

    Vestnik oftalmologii 2021; (137(5. Vyp. 2)):367-374 doi:10.17116/oftalma2021137052367.

    PMID: 34669350
  5. 5

    Frequent hypomorphic alleles account for a significant fraction of ABCA4 disease and distinguish it from age-related macular degeneration.

    Zernant J, Lee W, Collison FT, et al.

    Journal of medical genetics 2017; (54(6)):404-412 doi:10.1136/jmedgenet-2017-104540.

    PMID: 28446513
  6. 6

    The Common ABCA4 Variant p.Asn1868Ile Shows Nonpenetrance and Variable Expression of Stargardt Disease When Present in trans With Severe Variants.

    Runhart EH, Sangermano R, Cornelis SS, et al.

    Investigative ophthalmology & visual science 2018; (59(8)):3220-3231 doi:10.1167/iovs.18-23881.

    PMID: 29971439
  7. 7

    Functional analysis and classification of homozygous and hypomorphic ABCA4 variants associated with Stargardt macular degeneration.

    Curtis SB, Molday LL, Garces FA, Molday RS

    Human mutation 2020; (41(11)):1944-1956 doi:10.1002/humu.24100.

    PMID: 32845050
  8. 8

    Extremely hypomorphic and severe deep intronic variants in the ABCA4 locus result in varying Stargardt disease phenotypes.

    Zernant J, Lee W, Nagasaki T, et al.

    Cold Spring Harbor molecular case studies 2018; (4(4)) doi:10.1101/mcs.a002733.

    PMID: 29848554
  9. 9

    Rare and common variants in ROM1 and PRPH2 genes trans-modify Stargardt/ABCA4 disease.

    Zernant J, Lee W, Wang J, et al.

    PLoS genetics 2022; (18(3)):e1010129 doi:10.1371/journal.pgen.1010129.

    PMID: 35353811
  10. 10

    Late-onset Stargardt disease.

    Alsberge JB, Agarwal A

    American journal of ophthalmology case reports 2022; (26()):101429 doi:10.1016/j.ajoc.2022.101429.

    PMID: 35243166
  11. 11

    Diagnostic Challenges in ABCA4-Associated Retinal Degeneration: One Gene, Many Phenotypes.

    Tan TE, Tang RWC, Chan CM, et al.

    Diagnostics (Basel, Switzerland) 2023; (13(23)) doi:10.3390/diagnostics13233530.

    PMID: 38066771
  12. 12

    Multimodal in-vivo maps as a tool to characterize retinal structural biomarkers for progression in adult-onset Stargardt disease.

    Pedersen HR, Gilson SJ, Hagen LA, et al.

    Frontiers in ophthalmology 2024; (4()):1384473 doi:10.3389/fopht.2024.1384473.

    PMID: 38984108

This page is for informational purposes only and does not constitute medical advice. An ophthalmologist or inherited-retinal-disease specialist should interpret your examination, imaging, and genetic results.

Get notified when new evidence is published on Stargardt disease.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.